OverviewSuggest Edit

uMotif is a company that develops a patient-centric data capture platform for research. It captures electronic clinical outcome assessment (eCOA), electronic patient-reported outcome (ePRO), electronic diaries, eConsent, symptom, and wearables data to support new insights. uMotif serves academics, CROs, as well as biotech, medical device, and pharmaceutical companies.

HQLondon, GB
Employee Ratings4

Latest Updates

Employees (est.) (Sept 2021)78(+6%)
Cybersecurity ratingAMore

Key People/Management at uMotif

Bruce Hellman

Bruce Hellman

CEO & Co-Founder
Jonathan Moshinsky

Jonathan Moshinsky

Chief Strategy Officer
Ben James

Ben James

Chief Product Officer & Co-Founder
Prakash Shah

Prakash Shah

Chief Financial Officer
Simon Brooks

Simon Brooks

Chief Delivery Officer
Brian Collins

Brian Collins

Quality Assurance Director
Show more

uMotif Office Locations

uMotif has an office in London
London, GB (HQ)
10 York Rd, South Bank
Show all (1)

uMotif Financials and Metrics

Summary Metrics

Founding Date


uMotif total Funding

$9.9 m

uMotif latest funding size

$6.67 m

Time since last funding

a year ago

uMotif investors

uMotif's latest funding round in September 2020 was reported to be $6.7 m. In total, uMotif has raised $9.9 m
Show all financial metrics

uMotif Operating Metrics

Sep, 2020

Countries Covered

Show all operating metrics

uMotif Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

uMotif Online and Social Media Presence

Embed Graph

uMotif News and Updates

VirTrial and uMotif Partner to Further Expand Decentralized Clinical Trial Capabilities

SCOTTSDALE, Ariz., March 9, 2021 /PRNewswire/ -- VirTrial, the leading provider of telemedicine technology, and uMotif, the patient-centric data capture platform provider, are joining forces to combine their Decentralized Clinical Trial (DCT) technologies in one seamlessly integrated...

MedTech startup uMotif raises £5m from AlbionVC, as COVID-19 accelerates remote clinical studies

couMotif has an app that allows patients to monitor themselves for treatments or drug trials which then feeds into a platform allowing a much faster approach to clinical studies. It’s now raised £5 million in a Series A investment round led by existing UK investor AlbionVC, with participation from O…

London’s uMotif secures £5 million to decentralise clinical trials and get therapies to patients faster

London-based uMotif, a software that captures patient data for clinical studies, has raised £5 million in a Series A round led by existing investor AlbionVC, with participation from Norwegian firm DNV GL and angel investors. By creating a more engaging experience for study participants, uMotif aims …

uMotif Frequently Asked Questions

  • When was uMotif founded?

    uMotif was founded in 2012.

  • Who are uMotif key executives?

    uMotif's key executives are Bruce Hellman, Jonathan Moshinsky and Ben James.

  • How many employees does uMotif have?

    uMotif has 78 employees.

  • Who are uMotif competitors?

    Competitors of uMotif include Medionce Solutions, Artifact Health and Doctrin.

  • Where is uMotif headquarters?

    uMotif headquarters is located at 10 York Rd, South Bank, London.

  • Where are uMotif offices?

    uMotif has an office in London.

  • How many offices does uMotif have?

    uMotif has 1 office.